The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis

Table 1

Clinical characteristics of the patients.

(a)

Variable	Endometriosis group ()		Controls ()		value
	Min.-max.		Min.-max.
Age (years)	18-44		17-40		0.942
BMI (kg/m^2)	18-34		18-40		0.194
Cr	25-557	173^† (113) ^††	35-601	147^† (133) ^††	0.885

(b)

		Frequency (percent)	Frequency(percent)
Marital status	Single	7 (14.9)	4 (10.8)	0.415
	Married	40 (85.1)	33 (89.2)
Gravidity	0	23 (48.9)	11 (29.7)	0.199
	1	11 (23.4)	11 (29.7)
	2-5	13 (27.7)	15 (40.5)
Parity	0	24 (51.1)	13 (35.1)	0.201
	1	14 (29.8)	11 (29.7)
	2-5	9 (19.1)	13 (35.1)
Abortion	0	41 (87.2)	32 (86.5)	0.585
	1-2	6 (12.8)	5 (13.5)
Smoking	Yes	0 (0)	1 (2.8)	0.440
	No	47 (100)	36 (97.2)
Stage of endometriosis	1	1 (2.1)	—	—
	2	7 (14.9)	—
	3	12 (25.5)	—
	4	27 (57.5)	—
Menstrual phase	Follicular phase	29 (61.7)	20 (54)	0.511
	Luteal phase	18 (38.3)	17 (46)
Menstrual pattern	Regular	29 (61.7)	21 (56.7)	0.806
	Irregular	17 (36.2)	16 (43.3)
	Amenorrhea	1 (2.1)	0
Infertility	Yes	19 (40.4)	12 (32.4)	0.501
	No	28 (59.6)	25 (67.6)

Results of the Mann-Whitney test; results of the chi-square test or the Fisher exact test, ^† median, ^†† IQR.